Apollo Endosurgery Inc HQ8F-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 06/11/21 CEST
6.25quote price arrow up+0.05 (+0.81%)
Volume
50
52 week range
1.06 - 8.00

...

Loading . . .
  • Open6.35
  • Day High6.35
  • Day Low6.25
  • Prev Close6.35
  • 52 Week High8.00
  • 52 Week High Date03/01/21
  • 52 Week Low1.06
  • 52 Week Low Date09/10/20

Key Stats

  • Market Cap210.88M
  • Shares Out27.04M
  • 10 Day Average Volume12.5
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change128.1

KEY STATS

  • Open6.35
  • Day High6.35
  • Day Low6.25
  • Prev Close6.35
  • 52 Week High8.00
  • 52 Week High Date03/01/21
  • 52 Week Low1.06
  • 52 Week Low Date09/10/20
  • Market Cap210.88M
  • Shares Out27.04M
  • 10 Day Average Volume12.5
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change128.1

RATIOS/PROFITABILITY

  • EPS (TTM)-0.61
  • P/E (TTM)-10.25
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Apollo Endosurgery Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Apollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company's device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries. The Company's products include ORBERA, LAP-BAND and OverStitch. The Company's product, ORBERA, is a gastric balloon. The ORBERA...
Charles McKhann
President
Stefanie Cavanaugh CPA
Chief Financial Officer
John Molesphini
Executive Vice President
Bret Schwartzhoff
Vice President
Address
1120 South Capital Of Tx Hwy
Building 1 Suite 300
West Lake Hills, TX
78746-6464
United States